ZA200308666B - Minoxidil-containing liquid composition. - Google Patents
Minoxidil-containing liquid composition. Download PDFInfo
- Publication number
- ZA200308666B ZA200308666B ZA200308666A ZA200308666A ZA200308666B ZA 200308666 B ZA200308666 B ZA 200308666B ZA 200308666 A ZA200308666 A ZA 200308666A ZA 200308666 A ZA200308666 A ZA 200308666A ZA 200308666 B ZA200308666 B ZA 200308666B
- Authority
- ZA
- South Africa
- Prior art keywords
- minoxidil
- liquid
- liquid composition
- arginine
- color development
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 69
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 229960003632 minoxidil Drugs 0.000 title claims abstract description 31
- 239000004475 Arginine Substances 0.000 claims abstract description 29
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000011161 development Methods 0.000 claims abstract description 27
- 238000002360 preparation method Methods 0.000 claims abstract description 27
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 235000019441 ethanol Nutrition 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 8
- 230000003659 hair regrowth Effects 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 235000013772 propylene glycol Nutrition 0.000 claims description 3
- 238000004321 preservation Methods 0.000 abstract description 2
- 235000009697 arginine Nutrition 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 238000009472 formulation Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 201000008009 Early infantile epileptic encephalopathy Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- -1 alkylene glycols Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000013257 developmental and epileptic encephalopathy Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001145028 | 2001-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200308666B true ZA200308666B (en) | 2004-11-08 |
Family
ID=18990901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200308666A ZA200308666B (en) | 2001-05-15 | 2002-05-14 | Minoxidil-containing liquid composition. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040162301A1 (fr) |
| EP (1) | EP1393732B1 (fr) |
| JP (1) | JP4189223B2 (fr) |
| AT (1) | ATE368463T1 (fr) |
| AU (1) | AU2002255354B2 (fr) |
| BR (1) | BR0209602A (fr) |
| CA (1) | CA2448195A1 (fr) |
| DE (1) | DE60221522T2 (fr) |
| MX (1) | MXPA03010458A (fr) |
| NO (1) | NO20035091D0 (fr) |
| NZ (1) | NZ529436A (fr) |
| RU (1) | RU2288720C2 (fr) |
| UA (1) | UA80094C2 (fr) |
| WO (1) | WO2002092092A1 (fr) |
| ZA (1) | ZA200308666B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1269972T3 (da) * | 2000-04-07 | 2006-02-13 | Taisho Pharmaceutical Co Ltd | Harvakststimulerende sammensatninger med forhalet virkning |
| JP2009040746A (ja) * | 2007-08-10 | 2009-02-26 | Sansho Kaken Kk | 化粧液 |
| JP5622187B2 (ja) * | 2009-09-08 | 2014-11-12 | 群泰生物科技股▲ふん▼有限公司 | 水溶性ミノキシジル組成物 |
| JP6067036B2 (ja) * | 2013-01-31 | 2017-01-25 | 富士フイルム株式会社 | 乳化組成物 |
| CN104832443B (zh) * | 2015-05-25 | 2017-05-24 | 广东美的环境电器制造有限公司 | 风扇 |
| BR102021003531A2 (pt) | 2021-02-24 | 2022-08-30 | Eurofarma Laboratorios S.A. | Composição farmacêutica tópica espumável |
| CN115501178B (zh) * | 2022-08-26 | 2023-05-19 | 山东京卫制药有限公司 | 含有米诺地尔的稳定的液体组合物及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0840907A (ja) * | 1994-08-03 | 1996-02-13 | Meiji Seika Kaisha Ltd | セファロスポリン注射剤 |
| JPH10279437A (ja) * | 1997-03-31 | 1998-10-20 | Shiseido Co Ltd | 頭髪用化粧料 |
| JP4390030B2 (ja) * | 1997-12-03 | 2009-12-24 | 大正製薬株式会社 | ミノキシジル配合液剤組成物 |
| JPH11263727A (ja) * | 1997-12-03 | 1999-09-28 | Taisho Pharmaceut Co Ltd | ミノキシジル配合液剤組成物 |
| AUPP310798A0 (en) * | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
| AU3596900A (en) * | 1999-02-19 | 2000-09-04 | Marcus R. Jones | Method and composition for promoting hair growth |
| US6228400B1 (en) * | 1999-09-28 | 2001-05-08 | Carlsbad Technology, Inc. | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| DK1269972T3 (da) * | 2000-04-07 | 2006-02-13 | Taisho Pharmaceutical Co Ltd | Harvakststimulerende sammensatninger med forhalet virkning |
| JP2002029935A (ja) * | 2000-07-17 | 2002-01-29 | Taisho Pharmaceut Co Ltd | 育毛剤 |
| DE10036799A1 (de) * | 2000-07-28 | 2002-02-07 | Beiersdorf Ag | Neues Mittel zur Behandlung der Haare und der Kopfhaut |
| US7442369B1 (en) * | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
| JP4554805B2 (ja) * | 2000-12-05 | 2010-09-29 | 花王株式会社 | 養毛料 |
-
2002
- 2002-05-14 AT AT02724781T patent/ATE368463T1/de not_active IP Right Cessation
- 2002-05-14 RU RU2003136096/15A patent/RU2288720C2/ru active
- 2002-05-14 CA CA002448195A patent/CA2448195A1/fr not_active Abandoned
- 2002-05-14 JP JP2002589009A patent/JP4189223B2/ja not_active Expired - Lifetime
- 2002-05-14 BR BR0209602-1A patent/BR0209602A/pt not_active IP Right Cessation
- 2002-05-14 US US10/477,358 patent/US20040162301A1/en not_active Abandoned
- 2002-05-14 UA UA20031211444A patent/UA80094C2/uk unknown
- 2002-05-14 ZA ZA200308666A patent/ZA200308666B/en unknown
- 2002-05-14 EP EP02724781A patent/EP1393732B1/fr not_active Expired - Lifetime
- 2002-05-14 MX MXPA03010458A patent/MXPA03010458A/es active IP Right Grant
- 2002-05-14 DE DE60221522T patent/DE60221522T2/de not_active Expired - Fee Related
- 2002-05-14 NZ NZ529436A patent/NZ529436A/en unknown
- 2002-05-14 WO PCT/JP2002/004657 patent/WO2002092092A1/fr active IP Right Grant
- 2002-05-14 AU AU2002255354A patent/AU2002255354B2/en not_active Ceased
-
2003
- 2003-11-14 NO NO20035091A patent/NO20035091D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2002092092A1 (ja) | 2004-10-21 |
| CA2448195A1 (fr) | 2002-11-21 |
| BR0209602A (pt) | 2004-03-23 |
| EP1393732A4 (fr) | 2004-10-13 |
| DE60221522D1 (de) | 2007-09-13 |
| UA80094C2 (en) | 2007-08-27 |
| RU2003136096A (ru) | 2005-04-10 |
| AU2002255354B2 (en) | 2007-03-22 |
| WO2002092092A1 (fr) | 2002-11-21 |
| RU2288720C2 (ru) | 2006-12-10 |
| EP1393732A1 (fr) | 2004-03-03 |
| EP1393732B1 (fr) | 2007-08-01 |
| MXPA03010458A (es) | 2004-03-09 |
| US20040162301A1 (en) | 2004-08-19 |
| JP4189223B2 (ja) | 2008-12-03 |
| DE60221522T2 (de) | 2008-04-10 |
| NO20035091D0 (no) | 2003-11-14 |
| NZ529436A (en) | 2004-11-26 |
| ATE368463T1 (de) | 2007-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4661340A (en) | Quail egg based stabilized foam compositions for cosmetic purposes | |
| JP4780429B2 (ja) | ミノキシジル含有製剤 | |
| JP5527787B2 (ja) | 育毛組成物 | |
| CA1202908A (fr) | Melange stable de poudre et d'alcool | |
| ZA200308666B (en) | Minoxidil-containing liquid composition. | |
| ES2242657T3 (es) | Composicion de vitaminas particular. | |
| US7153888B2 (en) | Stabilization of benzoyl peroxide in solution | |
| PH26546A (en) | Topical preparation containing ofloxacin | |
| JP4390030B2 (ja) | ミノキシジル配合液剤組成物 | |
| JPH11302162A (ja) | トラニラスト水溶液製剤 | |
| JP4796260B2 (ja) | ミノキシジル含有製剤 | |
| JPS605567B2 (ja) | オキシテトラサイクリンの調合液 | |
| US6346257B1 (en) | Process for preparing water-in-oil type emulsion cosmetic composition containing L-ascorbic acid with improved stability | |
| US5480460A (en) | Method for improving the stability in air of a hair dye concentrate | |
| JPH10236951A (ja) | プラノプロフェン配合点眼剤 | |
| US20070077261A1 (en) | Compositions and method for enhancing the solubility of ascorbic acid using solubilization enhancers | |
| JPH0129170B2 (fr) | ||
| JP2021134164A (ja) | ミノキシジル及びパントテニールエチルエーテルを含有する育毛外用剤、並びにそのパントテニールエチルエーテルの安定化及びミノキシジル等の結晶化抑制方法 | |
| AU682064B2 (en) | Liquid anthelmintic selenium compositions | |
| JPH11263727A (ja) | ミノキシジル配合液剤組成物 | |
| JP2004196671A (ja) | 水溶性アズレン含有点眼剤 | |
| BG107988A (bg) | Стабилизирани препарати за локално третиране с бривудин | |
| CA1335574C (fr) | Composition de (benzo-1,2-4-thiadiazine)-1,1-dioxyde en solution | |
| JP2001261559A (ja) | 高濃度ビタミンｃ組成物及びその調製方法 | |
| JP7346838B2 (ja) | 外用医薬組成物 |